Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad

Thyroid. 2021 Jun;31(6):985-993. doi: 10.1089/thy.2020.0649. Epub 2021 Mar 18.

Abstract

Background: The monocarboxylate transporter 8 (Mct8) protein is a primary thyroxine (T4) and triiodothyronine (T3) (thyroid hormone [TH]) transporter. Mutations of the MCT8-encoding, SLC16A2 gene alter thyroid function and TH metabolism and severely impair neurodevelopment (Allan-Herndon-Dudley syndrome [AHDS]). Mct8-deficient mice manifest thyroid alterations but lack neurological signs. It is believed that Mct8 deficiency in mice is compensated by T4 transport through the Slco1c1-encoded organic anion transporter polypeptide 1c1 (Oatp1c1). This allows local brain generation of sufficient T3 by the Dio2-encoded type 2 deiodinase, thus preventing brain hypothyroidism. The Slc16a2/Slco1c1 (MO) and Slc16a2/Dio2 (MD) double knockout (KO) mice lacking T4 and T3 transport, or T3 transport and T4 deiodination, respectively, should be appropriate models of AHDS. Our goal was to compare the cerebral hypothyroidism of systemic hypothyroidism (SH) caused by thyroid gland blockade with that present in the double KO mice. Methods: We performed RNA sequencing by using RNA from the cerebral cortex and striatum of SH mice and the double KO mice on postnatal days 21-23. Real-time polymerase chain reaction was used to confirm RNA-Seq results in replicate biological samples. Cell type involvement was assessed from cell type-enriched genes. Functional genomic differences were analyzed by functional node activity based on a probabilistic graphical model. Results: Each of the three conditions gave a different pattern of gene expression, with partial overlaps. SH gave a wider and highest variation of gene expression than MD or MO. This was partially due to secondary gene responses to hypothyroidism. The set of primary transcriptional T3 targets showed a tighter overlap, but quantitative gene responses indicated that the gene responses in SH were more severe than in MD or MO. Examination of cell type-enriched genes indicated cellular differences between the three conditions. Conclusions: The results indicate that the neurological impairment of AHDS is too severe to be fully explained by TH deprivation only.

Keywords: blood–brain barrier; cerebral cortex; deiodinases; hypothyroidism; striatum; transporters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain / physiopathology
  • Cerebral Cortex / metabolism
  • Gene Expression Profiling
  • Gene Expression*
  • Hypothyroidism / genetics*
  • Hypothyroidism / metabolism
  • Hypothyroidism / physiopathology
  • Iodide Peroxidase / genetics*
  • Iodide Peroxidase / metabolism
  • Iodothyronine Deiodinase Type II
  • Mental Retardation, X-Linked / genetics*
  • Mental Retardation, X-Linked / metabolism
  • Mental Retardation, X-Linked / physiopathology
  • Mice
  • Mice, Knockout
  • Monocarboxylic Acid Transporters / genetics*
  • Monocarboxylic Acid Transporters / metabolism
  • Muscle Hypotonia / genetics*
  • Muscle Hypotonia / metabolism
  • Muscle Hypotonia / physiopathology
  • Muscular Atrophy / genetics*
  • Muscular Atrophy / metabolism
  • Muscular Atrophy / physiopathology
  • Neostriatum / metabolism
  • Organic Cation Transport Proteins / genetics*
  • Organic Cation Transport Proteins / metabolism
  • Symporters / genetics*
  • Symporters / metabolism
  • Thyroxine / metabolism*
  • Triiodothyronine / metabolism*

Substances

  • Monocarboxylic Acid Transporters
  • Oatp2 protein, mouse
  • Organic Cation Transport Proteins
  • Slc16a2 protein, mouse
  • Symporters
  • Triiodothyronine
  • Iodide Peroxidase
  • Thyroxine

Supplementary concepts

  • Allan-Herndon-Dudley syndrome